By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Wealth Beat NewsWealth Beat News
  • Home
  • News
  • Finance
  • Investing
  • Banks
  • Mortgage
  • Loans
  • Credit Cards
  • Small Business
  • Dept Management
Notification Show More
Aa
Wealth Beat NewsWealth Beat News
Aa
  • News
  • Finance
  • Investing
  • Banks
  • Mortgage
  • Loans
  • Credit Cards
  • Small Business
  • Dept Management
Follow US
Wealth Beat News > News > Microsoft: OpenAI Drama A Huge Negative (NASDAQ:MSFT)
News

Microsoft: OpenAI Drama A Huge Negative (NASDAQ:MSFT)

News
Last updated: 2023/11/27 at 12:23 AM
By News
Share
7 Min Read
SHARE

Contents
OpenAI DysfunctionSteep Value JumpTakeaway

While the OpenAI drama showed Microsoft (NASDAQ:MSFT) as a crucial partner for Sam Altman, the situation proved customers need access to other AI sources. The stock soared to all-time highs on signs of a coup of hiring the King of AI, but a week of drama left Sam back at an OpenAI with a restructured BoD. My investment thesis is more Neutral on Microsoft after the nearly 20% rally in the stock since my previous research and the negatives of the OpenAI drama.

Finviz Chart

Source: Finviz

OpenAI Dysfunction

Back on November 17, CEO Sam Altman was fired from OpenAI by a BoD claiming he wasn’t candid with the oversight group. Microsoft owns 49% of OpenAI and didn’t appear happy with the move leading to an offer to hire the AI leader and other employees looking to exit the original non-profit firm.

After at least 90% of the employees threatened to leave OpenAI, Microsoft and other economic forces were able to negotiate a return of Sam Altman to the CEO position of OpenAI with a new BoD. The drama lasted 6 days and led to signs of ChatGPT outages.

Even worse, the Chief Scientist was involved in this attempt to oust Mr. Altman following the prior Chief Scientist leaving OpenAI after failing to push him out. The former Chief Scientist and other researchers formed competitor Anthropic back in 2021.

Alphabet (GOOG, GOOGL) recently invested $2 billion more in Anthropic to fund the competitor formed by OpenAI employees dissatisfied with the leadership of Sam Altman. The AI startup will even use TPUs from Google, and Amazon (AMZN) has reportedly invested up to $4 billion in the AI firm. The following OpenAI employees co-founded Anthropic.

  • Dario Amodei – CEO, former VP of Research at OpenAI
  • Jack Clark – former policy director and communications at OpenAI
  • Tom Brown – technical staff at OpenAI
  • Sam McCandlish – Research Leader at OpenAI

With Sam Altman and President Greg Brockman back running OpenAI, investors need to note a new BoD guiding the organization. Bret Taylor, Larry Summers, and Adam D’Angelo are a more formidable board, though ones unlikely to have the core mission of public safety for AI as the prior BoD.

Twitter post

Source: OpenAI

An unleashed Sam Altman without a BoD structured for public safety and benefiting all humanity might actually further grow generative AI leadership. The board members led by Georgetown Center for Security and Emerging Technology’s Helen Toner and OpenAI chief scientist Ilya Sutskever aren’t around to slow down AI due to safety reasons.

At the end of the day, 100s of customers apparently approached Anthropic, Google Cloud, and AI startup Cohere to pursue alternative AI services. In addition, Microsoft apparently is running into issues in competing with OpenAI in signing up customers even more impacted as Mr. Altman likely pivots even further to commercialization opportunities, unlike the prior structure with efforts to shackle those moves.

Microsoft definitely benefits from the large investment in an OpenAI worth up to $90 billion, but the company also doesn’t fully control the technology. All of the value derived by OpenAI doesn’t exactly flow into Microsoft unless it shows up as revenue for the tech giant.

Steep Value Jump

While Microsoft is full speed ahead with Copilot and other AI products, enterprises are only slowly purchasing new AI software tools. The tech giant only guided to FQ2 revenues of $60.6 billion for 15% growth.

While Microsoft has a huge growth opportunity due to AI, the stock has now rushed ahead of the real world potential. The company already generates $240 billion in annual revenues and an estimated $100 billion AI boost in the next few years is a great boost, but not a monumental move considering the relative size of Microsoft already.

The stock has a market cap of nearly $3 trillion now with FY24 (June) revenues of $243 billion. Revenue is only forecast to grow at a 15% clip while trading at nearly 12x sales. In fact, the stock already trades at 7x FY28 revenue of $405 billion, suggesting the stock price might not rally for the next 5 years. All of the other tech giants now trade at vast discounts to Microsoft with Alphabet and Meta Platforms (META) trading at half the forward PS ratio at only 6x.

Chart
Data by YCharts

The stock could definitely run much higher in the next few weeks and months. A lot of analysts came out with $400+ price targets. The odd part is that the consensus price target is now only $406 for just 7.6% upside with Microsoft having 35 Strong Buy ratings out of 53 total ratings.

Analyst Ratings table

Source: Seeking Alpha

In essence, the majority of analysts are already fully bullish on the stock, offering limited additional upside from here. Investors will want to look at $400 as more of an exit point, not an entry point.

Takeaway

The key investor takeaway is that the OpenAI drama might not harm the AI business, but the drama has definitely made enterprises investigate alternative AI sources. Microsoft already trades at a premium valuation and a stretched valuation to tech peers. Investors should use any further rally toward the consensus price target as an opportunity to exit the stock at the peak and realize this isn’t the starting point for a major AI rally over the next few years.

Read the full article here

News November 27, 2023 November 27, 2023
Share this Article
Facebook Twitter Copy Link Print
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Fast Four Quiz: Precision Medicine in Cancer

How much do you know about precision medicine in cancer? Test your knowledge with this quick quiz.
Get Started
Excelerate Energy: Nearby Best Energy-Source Cap-Gain Prospect (NYSE:EE)

The primary focus of this article is Excelerate Energy, Inc. (NYSE:EE). Investment…

Penske Is Steady, But The Road Ahead May Be Bumpy (NYSE:PAG)

Investing Thesis On Wednesday, Penske Automotive Group (NYSE:PAG) released a superficially encouraging…

Top Financial – No, Stop It, This Is Silly (NASDAQ:TOP)

TOP Financial Moves, yes, but why? TOP Financial (NASDAQ:TOP) was quite the…

You Might Also Like

News

Reckitt Benckiser Group Plc. ADR (RBGLY) Focus On Emerging Markets: Growth Opportunities and Strategic Capabilities Discussion Transcript

By News
News

NIE CEF: Reliable Dividends While Maintaining Exposure To Technology (NYSE:NIE)

By News
News

Jacobs Stock: Growth Driven By Strong Backlog And Increasing AI Infrastructure Demand (J)

By News
News

Kinder Morgan Stock: I Would’ve Entered If Not For Liquidity And Valuation Risks (KMI)

By News
Facebook Twitter Pinterest Youtube Instagram
Company
  • Privacy Policy
  • Terms & Conditions
  • Contact US
More Info
  • Newsletter
  • Finance
  • Investing
  • Small Business
  • Dept Management

Sign Up For Free

Subscribe to our newsletter and don't miss out on our programs, webinars and trainings.

I have read and agree to the terms & conditions

Join Community

2025 © wealthbeatnews.com. All Rights Reserved.

Join Us!

Subscribe to our newsletter and never miss our latest news, podcasts etc.

I have read and agree to the terms & conditions
Zero spam, Unsubscribe at any time.
Welcome Back!

Sign in to your account

Lost your password?